CAAS Capital Management’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-40,000	Closed	-$1.4M	–	558
2020 Q3	$1.4M	Buy	+40,000	New	+$1.4M	0.03%	160